SLC1A5/ASCT2 Monoklonaler Antikörper

SLC1A5/ASCT2 Monoklonal Antikörper für WB, IHC, IF/ICC, IF-Fro, FC (Intra), Indirect ELISA

Wirt / Isotyp

Maus / IgG1

Getestete Reaktivität

human

Anwendung

WB, IHC, IF/ICC, IF-Fro, FC (Intra), Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

1C4E1

Kat-Nr. : 68540-1-PBS

Synonyme

SLC1A5, 1C4E1, AAAT, ASCT2, ATB(0)



Geprüfte Anwendungen

Produktinformation

68540-1-PBS bindet in WB, IHC, IF/ICC, IF-Fro, FC (Intra), Indirect ELISA SLC1A5/ASCT2 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Maus / IgG1
Klonalität Monoklonal
Typ Antikörper
Immunogen SLC1A5/ASCT2 fusion protein Ag16837
Vollständiger Name solute carrier family 1 (neutral amino acid transporter), member 5
Berechnetes Molekulargewicht 541 aa, 57 kDa
Beobachtetes Molekulargewicht 55-70 kDa
GenBank-ZugangsnummerBC000062
Gene symbol SLC1A5/ASCT2
Gene ID (NCBI) 6510
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein-G-Reinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

SLC1A5 (Solute Carrier Family 1, member 5), also named as ASCT2, a major glutamine transporter belonging to the SLC1 family and localized in the plasma membrane of several body districts. Consistent with the functions exerted by glutamine, SLC1A5 is involved in uptake of essential amino acids, activation of mTORC1 and glutamine-dependent tumor cell survival and growth. SLC1A5 is highly expressed in various malignancies and plays a critical role in the transformation, growth and survival of cancer cells (PMID: 30234109). High SLC1A5 expression is associated with poor prognosis in clear-cell renal cell carcinoma (PMID: 26599282).